Answers are grounded in this paper and cite their sources.
Background/Objectives: The rapid growth of big data in healthcare creates opportunities for patient care and health-system management but also raises ethical challenges concerning privacy, consent, security, transparency, and equity. This systematic review synthesized the literature on the role of ethics in the use of big data in healthcare information management and identified ethical frameworks, dilemmas, governance mechanisms, current practices, and gaps. Methods: The review followed PRISMA 2020 and was not registered. Google Scholar, ScienceDirect, and PubMed were searched (18 November–29 December 2025) for English-language journal articles published in 2018–2022. Two reviewers screened records independently; the full texts of all 20 included articles were appraised with Joanna Briggs Institute (JBI) tools using explicit decision rules. Findings were synthesized narratively following the SWiM guideline and mapped in a study-by-theme evidence matrix; no meta-analysis was performed. Results: Of 103,218 records identified, 20 articles were included (ten narrative reviews, five conceptual or ethico–legal analyses, two commentaries, one qualitative study, one multi-criteria empirical study, and one bibliometric analysis); ethical content was central or substantive in fourteen and limited in six. Quality was high in seven, moderate in ten, and low in three articles. The main findings were re-identification risk and the erosion of the boundary between identifiable and anonymized data; consent that does not scale to secondary and algorithmic uses; group harms and mistrust; and inconsistent implementation of existing rules. Only two studies reported primary empirical data, and none evaluated whether governance mechanisms work. Conclusions: Ethical use of big data in healthcare information management requires adaptive governance, layered consent, continuing re-identification risk management, transparent accountability, ethics education, and patient and community engagement. Priority research includes empirical evaluation of governance frameworks, patients’ views on secondary use, and AI-driven applications. Limitations: heterogeneous and largely conceptual evidence; a three-term search; partial screening of Google Scholar results; the 2018–2022 window; and no certainty-of-evidence assessment. Funding: none. Registration: not registered.
No takes yet. Share an insight, caveat, or question.
Aldousari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: